Merus N.V.
MRUS
Equity
ISIN NL0011606264 / Valor 32548496
NASDAQ (2024-09-13)
USD 50.14+2.04%
Merus N.V.
UMushroom community rating:
About company
Merus N.V. is a clinical-stage oncology company focused on developing innovative, full-length multispecific antibodies for cancer treatment.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
108%1Y
88.6%3Y
199%5Y
Performance
58.2%1Y
65.2%3Y
69.0%5Y
Volatility
3352 M
Market cap (USD)
150,983
Daily traded volume (Shares)
50.5 / 49.37
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
0.002022
0.002023
0.002024
Est dividend (USD)
0.00%2022
0.00%2023
0.00%2024
Est dividend yield
P/E ratio
00.002022
00.002023
00.002024
Est P/E ratio
EPS (USD)
0.002022
0.002023
0.002024
Est EPS (USD)
Ratings & reviews
Performance:
0.00
Innovation:
0.00
Society:
0.00
Nature:
0.00
EQUITIES OF THE SAME SECTOR
